Quick Answer
QuidelOrtho Corp reported Cash and Equivalents of $169.80 million for fiscal year 2025.
QuidelOrtho Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $169.80M | +72.7% |
| 2024 | $98.30M | -17.3% |
| 2023 | $118.90M | -59.4% |
| 2022 | $292.90M | -63.5% |
| 2021 | $802.80M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $98.10M | -31.7% | -35.3% |
| June 30, 2025 | $151.70M | +41.8% | +19.4% |
| March 31, 2025 | $127.10M | +61.9% | +29.3% |
| December 31, 2024 | $98.30M | -17.3% | -31.6% |
| September 30, 2024 | $143.70M | -3.8% | +34.3% |
| June 30, 2024 | $107.00M | -40.1% | +36.3% |
| March 31, 2024 | $78.50M | -77.8% | -34.0% |
| December 31, 2023 | $118.90M | -59.4% | -20.4% |
- QuidelOrtho Corp showed an increase of +72.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, QuidelOrtho Corp’s cash and equivalents has declined by 78.8% (from $802.80 million to $169.80 million).
- The most recent figure is from QuidelOrtho Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: